Business
Medical Care Technologies (OTC Pink:MDCE) Outlines Regulatory Roadmap: Dividing AI Health Platform Into Clinical and Consumer Divisions
MESA, ARIZONA / ACCESS Newswire / October 7, 2025 / Medical Care Technologies Inc. (OTC Pink:MDCE), an emerging innovator in AI-driven preventive healthcare, today announced its strategic plan to separate its artificial intelligence health applications ...
About this update from Medical Care Technologies Inc.
[{"type":"text","content":"MESA, ARIZONA / ACCESS Newswire / October 7, 2025 / Medical Care Technologies Inc. (OTC Pink:MDCE), an emerging innovator in AI-driven preventive healthcare, today announced its strategic plan to separate its artificial intelligence health applications into two distinct divisions - one designed for clinical validation and regulatory approval, and another tailored for consumer and research-based wellness monitoring.","length":418,"tagName":"p"},{"type":"image","alt":"","displaySize":"","headline":null,"caption":"","credit":"Medical Care Technologies Inc.","className":"","disableSlideshowImg":false,"size":{"original":{"width":1080,"height":1920,"url":"https://media.zenfs.com/en/accesswire.ca/41f76218fc79b74ea48bce2dceb7fec0"},"resized":{"url":"https://s.yimg.com/ny/api/res/1.2/sPaZw8h1P4zP5qA02bqx_g--/YXBwaWQ9aGlnaGxhbmRlcjt3PTk2MDtoPTE3MDc7Y2Y9d2VicA--/https://media.zenfs.com/en/accesswire.ca/41f76218fc79b74ea48bce2dceb7fec0","width":960,"height":1707},"lightbox":{"url":"https://s.yimg.com/ny/api/res/1.2/3RQ62qvLXJCmtBKfzK2WbA--/YXBwaWQ9aGlnaGxhbmRlcjt3PTIxNjA7aD0zODQwO2NmPXdlYnA-/https://media.zenfs.com/en/accesswire.ca/41f76218fc79b74ea48bce2dceb7fec0","width":1080,"height":1920}}},{"type":"text","content":"The company's proprietary platform integrates multiple diagnostic and predictive modules powered by deep learning, computer vision, and biometric analytics. As part of its responsible development roadmap, MDCE has identified which components align with recognized medical datasets, regulatory pathways, and FDA validation potential - and which are best positioned for general wellness and behavioral research markets.","length":421,"tagName":"p"},{"type":"text","content":"Clinical Division: FDA-Eligible Modules","length":39,"tagName":"p"},{"type":"text","content":"MDCE's Clinical AI Division looks tol include technologies and datasets that can be recognized and supported by the medical community and can advance through regulated validation processes such as FDA 510(k) or De Novo pathways. These modules include:","length":255,"tagName":"p"},{"type":"list","items":[{"val":[{"type":"text","content":"Dermatological Screening:Using established, peer-reviewed datasets, MDCE's skin lesion analysis engine will target early detection of melanoma and related conditions for integration into dermatological workflows.","length":2...